Thrombolytic Therapy is emergency treatment with medications to dissolve BLOOD clots that are in the process of forming. When initiated promptly, thrombolytic therapy can avert MYOCARDIAL INFARCTION or ischemic (nonhemorrhagic) STROKE, mitigating damage to the HEART or BRAIN respectively. Doctors also may use thrombolytic therapy to treat blood clots that form elsewhere in the body, such as in the leg (DEEP VEIN THROMBOSIS [DVT]) or the LUNGS (PULMONARY EMBOLISM).
Thrombolytic agents act by converting plasminogen, an inactive protein in the blood circulation, to plasmin, an active protein that breaks down the key proteins that form blood clots (fibrinogen and fibrin). These agents can only act before the clot fully forms and hardens, which establishes a therapeutic window of about four hours from the onset of clot formation. Early diagnosis is therefore essential.
|COMMON THROMBOLYTIC AGENTS|
|alteplase (aPA)||anisoylated purified streptokinase activator complex (APSAC)|
|tissue plasminogen activator (tPA)||urokinase|
The oldest of the thrombolytic agents is streptokinase, which doctors began using in the 1940s. Streptokinase and anistreplase derive from streptococcal BACTERIA. When administered, these agents initiate ANTIBODY production. The antibodies become active after five days and remain active for about six months. During that timeframe, doctors cannot re-administer streptokinase or anistreplase. Some people also have adverse responses to these agents, especially streptokinase. Laboratories manufacture most of the newer thrombolytic agents using recombinant technology, which nearly eliminates these immune responses.
The most significant risk of thrombolytic therapy is uncontrolled bleeding (HEMORRHAGE). For this reason, it is crucial for doctors to determine whether a stroke is ischemic (caused by a clot) or hemorrhagic (caused by bleeding) before administering a thrombolytic agent. For venous clots, such as with deep vein thrombosis, the doctor may directly inject the agent into the clot. For arterial clots, such as with myocardial infarction or stroke, the doctor injects the agent into a vein for distribution throughout the circulation. Thrombolytic agents remain active in the bloodstream for 15 to 90 minutes, depending on the agent. With prompt initiation of thrombolytic therapy, the agent dissolves the clot and the person experiences little or no adverse effects as a consequence of the thrombolytic event.
See also ANTICOAGULANT THERAPY; IMMUNE RESPONSE.
Resource: Facts On File Encyclopedia Of Health And Medicine
Aerobic Fitness and Cardiovascular System The efficiency with which the cardiovascular system functions to meet the oxygen needs of cells throughout the body, particularly under the increased pressure of intense physical activity or exercise. The higher a person’s aerobic FITNESS LEVEL, the more air the LUNGS can take in each breath, the more oxygen
The most significant age-related changes in cardiovascular function occur at birth in both sexes and with MENOPAUSE in women. Though changes in METABOLISM occur with aging that affect all body systems, researchers now believe cardiovascular health does not inherently decline simply as a function of aging. DIABETES, OBESITY, lack of physical exercise, and
What is Aneurysm and Definition Aneurysm is a weakened and often distended (stretched) area in the wall of an ARTERY. Though an aneurysm may develop in any artery, the most common location is the descending or abdominal AORTA. An aneurysm is potentially life-threatening. The continual pressure of the BLOOD flowing through the artery pressures the weakened
What is Wolff-Parkinson-White syndrome Wolff-Parkinson-White syndrome - An inherited ARRHYTHMIA disorder in which an extra conduction pathway, called an accessory pathway, exists between the heart’s atria and ventricles. The accessory pathway allows the heart’s electrical pacing impulse to bypass the normal conductive route, reaching the
What is Ventricular Fibrillation Ventricular fibrillation - Rapid, irregular, ineffective contractions of the heart’s ventricles. Ventricular fibrillation quickly becomes fatal without treatment. The HEART cannot pump blood to the LUNGS or to the body when it is in ventricular fibrillation. Ventricular fibrillation is a life-threatening event that
What is Ventricular assist devices (VADs) Ventricular Assist Devices - Implanted mechanical pumps that aid the native HEART, taking over some of the workload of the ventricles. Several types of VADs are available, each with somewhat different features and functions. A VAD may assist the right or left ventricle, and in some cases both ventricles, as a
What is Venogram - diagnostic procedure Venogram is a diagnostic procedure to evaluate the flow of blood in the veins, usually in the legs. The cardiologist may use venogram to diagnose VARICOSE VEINS, VENOUS INSUFFICIENCY, or DEEP VEIN THROMBOSIS (DVT). For venogram, the radiologist injects a small amount of contrast dye into the affected VEIN network and
What is chronic Venous Insufficiency and Symptoms Venous insufficiency is a chronic condition in which the veins cannot adequately return BLOOD to the HEART, usually as a consequence of defective valves that allow blood to leak back and pool in the veins. Some people do not have valves in their veins, a circumstance that is a CONGENITAL ANOMALY. Venous
Vena Cava are the two largest veins in human body together called the venae. These veins collectively return deoxygenated BLOOD to the HEART. Both of them deplete all the blood into the right atrium. The superior vena cava, large but short vein, brings blood from the upper part of the organism, the head and upper limbs, and empties into the top of the right
What is Vein and Definition Vein - A blood vessel that carries BLOOD to the HEART. All veins except the PULMONARY VEINS carry deoxygenated blood; the pulmonary veins return oxygenated blood to the heart from the LUNGS. Because veins lack the muscular structure and contractile capability of arteries, they have valves that keep blood moving only in one